From: Development and validation of a patient-reported outcome measure for stroke patients
Sub-domain | Control | Rankin level | F | P | |||||
---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | ||||
SOS | 32.95 ± 3.02 | 27.90 ± 6.57 | 26.31 ± 6.20 | 24.85 ± 6.30 | 24.53 ± 6.35 | 25.98 ± 4.96 | 23.46 ± 6.96 | 25.652 | <0.001 |
COG | 19.33 ± 2.27 | 16.59 ± 3.80 | 15.69 ± 3.78 | 13.32 ± 3.32 | 13.33 ± 3.38 | 13.86 ± 3.31 | 13.42 ± 4.79 | 32.806 | <0.001 |
VEC | 19.43 ± 1.98 | 17.96 ± 3.09 | 16.45 ± 3.26 | 14.22 ± 2.82 | 12.54 ± 3.37 | 13.81 ± 3.00 | 12.62 ± 4.51 | 59.779 | <0.001 |
SHS | 23.61 ± 3.03 | 24.33 ± 1.59 | 19.39 ± 3.16 | 15.68 ± 2.03 | 12.19 ± 2.33 | 8.91 ± 1.94 | 5.59 ± 1.26 | 769.629 | <0.001 |
ANX | 22.85 ± 2.90 | 17.61 ± 5.03 | 17.55 ± 5.31 | 17.34 ± 4.31 | 16.88 ± 4.51 | 16.07 ± 5.17 | 15.93 ± 5.86 | 21.911 | <0.001 |
DEP | 24.11 ± 2.11 | 21.04 ± 4.26 | 19.09 ± 4.71 | 18.44 ± 4.30 | 17.83 ± 4.90 | 17.45 ± 5.13 | 17.87 ± 5.71 | 25.407 | <0.001 |
AVO | 19.36 ± 1.75 | 16.79 ± 3.38 | 15.29 ± 3.89 | 14.00 ± 3.89 | 14.10 ± 3.43 | 14.26 ± 4.02 | 14.70 ± 4.97 | 24.756 | <0.001 |
SOC | 14.49 ± 1.55 | 11.88 ± 3.87 | 9.03 ± 4.09 | 9.63 ± 2.95 | 9.95 ± 3.61 | 9.48 ± 3.70 | 8.72 ± 4.43 | 31.575 | <0.001 |
FAS | 8.76 ± 4.72 | 14.27 ± 4.82 | 14. 90 ± 3.95 | 15.12 ± 4.95 | 14.33 ± 4.35 | 15.48 ± 4.49 | 16.25 ± 4.56 | 28.217 | <0.001 |
SAT | -- | 24.19 ± 4.83 | 24.30 ± 4.32 | 22.90 ± 6.23 | 23.35 ± 5.61 | 21.88 ± 5.99 | 24.03 ± 5.40 | 1.929 | >0.050 |
n | 104 | 135 | 123 | 41 | 58 | 42 | 76 | Â | Â |